NEU 8.15% $13.27 neuren pharmaceuticals limited

If any new investors want a quick reference to potential...

  1. 2,047 Posts.
    lightbulb Created with Sketch. 490
    If any new investors want a quick reference to potential catalysts that could drive price appreciation in the near term, then this image from a very recent article by fund manager Karst Peak Capital, is as succinct as it gets. A comprehensive article surrounds this particular snip and I strongly suggest you seek out that article for the analysis and valuations from the KPC team. KPC is a major holder of NEU shares.

    As you can see below, there is a lot happening for Neuren in concert with its US partner Acadia Pharmaceuticals, in the not too distant future. Importantly, the list below is not inclusive of all the news that might occur in the period.

    Forum members might add to the list where they see important omissions...and put them up for discussion. Finally, DYOR!

    https://hotcopper.com.au/data/attachments/4170/4170757-a2b5f1a30705546665479e800eeb4938.jpg
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.27
Change
1.000(8.15%)
Mkt cap ! $1.696B
Open High Low Value Volume
$12.95 $13.39 $12.79 $9.854M 751.2K

Buyers (Bids)

No. Vol. Price($)
3 2545 $13.26
 

Sellers (Offers)

Price($) Vol. No.
$13.29 1443 2
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.